Deadline for Seed Grant applications falls March 1

Jan 31, 2020 Re-posted from the February 2020 issue of Vascular Specialist

Applications for the SVS Foundation’s Clinical Research Seed Grant program are due March 1.

This program is designed to spur interest and development of clinical investigators among SVS members, particularly junior members with limited prior experience as principal investigators. 

The grant provides direct support for pilot projects with the potential to become larger studies funded from either industry or government sources. 

One awardee will be selected in the spring and will receive a $25,000 grant for direct costs for one year. 

Clinical Research Seed Grant Challenge: A second recipient will be selected for the Clinical Research Seed Grant Challenge during the Vascular Annual Meeting. 

This is the second annual competition. In 2019, Efthymios (Makis) Avgerinos, MD, was declared the winner in the 90-minute challenge. Though stressful, it was rewarding, he said.

The competition sharpened everyone’s focus and prompted them to delve deeper into their research and eventually improve it, said Avgerinos. “I got some wonderful ideas on how to improve my project and how to move on to a bigger grant down the road.”

For more information, visit vsweb.org/ClinicalResearchSeedGrant.

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.